Search filters

List of works by Xavier Mariette

2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts

scientific article

2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren's syndrome: A consensus and data-driven methodology involving three international patient cohorts.

scientific article published on 26 October 2016

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

scientific article published on 06 August 2019

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

scientific article published on 05 August 2019

A Machine Learning Approach for High-Dimensional Time-to-Event Prediction With Application to Immunogenicity of Biotherapies in the ABIRISK Cohort

scientific article published on 07 April 2020

A Phase III Study Evaluating Continuation, Tapering, and Withdrawal of Certolizumab Pegol After One Year of Therapy in Patients With Early Rheumatoid Arthritis ⬇️

scientific article published on 30 June 2017

A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS).

scientific article published on 24 November 2016

A multi-parameter response prediction model for rituximab in rheumatoid arthritis.

scientific article published on 28 March 2017

A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome.

scientific article

A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA.

scientific article published on 4 April 2017

A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome

scientific article published on 19 September 2020

A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

scientific article

Abatacept therapy and safety management

scientific article published on May 2009

Abatacept therapy and safety management

scientific article published on March 2012

Accurate detection of changes in disease activity in primary Sjögren's syndrome by the European League Against Rheumatism Sjögren's Syndrome Disease Activity Index

scientific article

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

scholarly article

Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial

scientific article

Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trial

scientific article published on 29 July 2013

Advances in understanding the pathogenesis of primary Sjögren's syndrome

scientific article published on 16 July 2013

Alcohol is not the missing link between Porphyromonas gingivalis-related periodontitis and radiological progression in early rheumatoid arthritis: comment on 'Porphyromonas gingivalis experimentally induces periodontitis and an anti-CCP2-associated

scientific article published on 14 June 2019

Alopecia areata in a patient with rheumatoid arthritis treated with leflunomide

scientific article published in August 2002

Analysis of non-melanoma skin cancer across the tofacitinib rheumatoid arthritis clinical programme

scientific article

Anti-RNP positivity in primary Sjögren's syndrome is associated with a more active disease and a more frequent muscular and pulmonary involvement

scientific article published on 01 October 2019

Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR)

scientific article published on 01 June 2005

Anti-carbamylated protein antibodies presence in early arthritis with a poorer clinical and radiological outcome: data from the French ESPOIR cohort

scientific article published on 29 August 2017

Anti-cytokines in the treatment of inflammation

scientific article published on 01 March 2003

Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy

scientific article published on 01 July 2003

Anticentromere antibodies identify patients with Sjögren's syndrome and autoimmune overlap syndrome

scientific article published on 15 October 2007

Antidrug antibodies (ADAb) to tumour necrosis factor (TNF)-specific neutralising agents in chronic inflammatory diseases: a real issue, a clinical perspective

scientific article

Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study

article

Articular manifestations in patients with inflammatory bowel disease treated with vedolizumab

scientific article published on 07 April 2020

Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach

scientific article published on 20 March 2020

Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients

article

Association of Anti-Porphyromonas gingivalis Antibody Titers With Nonsmoking Status in Early Rheumatoid Arthritis: Results From the Prospective French Cohort of Patients With Early Rheumatoid Arthritis

scientific article published on July 2015

Association of an IRF5 gene functional polymorphism with Sjögren's syndrome

scientific article published on December 2007

Association of response to TNF inhibitors in rheumatoid arthritis with quantitative trait loci for and CD39

article

Association of rheumatoid arthritis with multiple sclerosis: report of 14 cases and discussion of its significance

scientific article published on 15 March 2006

Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome

scientific article

Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases

scientific article published on 30 September 2020

B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: a six-month, national, multicenter, open-label study

scientific article published on 01 April 2011

B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome

scientific article

B cells in the pathogenesis of primary Sjögren syndrome

scientific article published on 8 February 2018

B-cell-activating factor expressions in salivary epithelial cells after dsRNA virus infection depends on RNA-activated protein kinase activation

scientific article published in May 2009

Bacteremia in patients receiving TNF-alpha antagonists--a prospective multicenter study.

scientific article

Baseline autoantibodies preferentially impact abatacept efficacy in patients with rheumatoid arthritis who are biologic naïve: 6-month results from a real-world, international, prospective study

scientific article

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis ⬇️

scientific article published on December 1, 2011

Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

scientific article published on 14 December 2016

Both Systemic and Intra-articular Immunization with Citrullinated Peptides Are Needed to Induce Arthritis in the Macaque.

scientific article published on 20 December 2017

Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome

scientific article published on 4 December 2015

Brief Report: The Role of Rare Protein-Coding Variants in Anti-Tumor Necrosis Factor Treatment Response in Rheumatoid Arthritis.

scientific article

CCL19, a B cell chemokine, is related to the decrease of blood memory B cells and predicts the clinical response to rituximab in patients with rheumatoid arthritis.

scientific article published in September 2013

CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome

scientific article published on 01 May 2005

CTLA-4 +49A/G and CT60 gene polymorphisms in primary Sjögren syndrome

scientific article published on January 2007

CTLA-4 polymorphism and primary Sjögren's syndrome: authors' response.

scientific article published on 5 June 2007

Cardiovascular and selected comorbidities in early arthritis and early spondyloarthritis, a comparative study: results from the ESPOIR and DESIR cohorts

scientific article

Cardiovascular risk and rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

scientific article (publication date: July 2006)

Care needs to be taken when reviewing malignancy data reported from observational studies: comment on the article by Onel and Onel

scientific article published on 27 October 2010

Certolizumab, an anti-TNF safe during pregancy? The CRIB Study results: an interview with Professor Xavier Mariette

scientific article published in September 2017

Cervical syphilitic spondylodiscitis associated with neurosyphilis.

scientific article published on 26 May 2011

Characterization of CD4 T Cell Epitopes of Infliximab and Rituximab Identified from Healthy Donors

scientific article

Characterization of Phenotypes and Functional Activities of Leukocytes From Rheumatoid Arthritis Patients by Mass Cytometry

scientific article published on 18 October 2019

Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

scientific article

Chronic diarrhoea and risk of rheumatoid arthritis: findings from the French E3N-EPIC Cohort Study

scientific article published on 17 May 2020

Chronic inflammatory arthritis following checkpoint inhibitor therapy for cancer: game changing implications

scientific article published on 03 January 2020

Classification criteria for Sjogren's syndrome: we actually need to definitively resolve the long debate on the issue

scientific article published on 22 December 2012

Clinical and laboratory follow-up for treating and monitoring patients with ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion

scientific article published on 30 May 2007

Clinical relevance of RORγ positive and negative subsets of CD161+CD4+ T cells in primary Sjögren's syndrome

scientific article published on November 2016

Clinicogenomic factors of biotherapy immunogenicity in autoimmune disease: A prospective multicohort study of the ABIRISK consortium

scientific article published on 30 October 2020

Combination of the Schirmer I and Phenol Red Thread Tests as a Rescue Strategy for Diagnosis of Ocular Dryness Associated with Sjögren's Syndrome ⬇️

scientific article published on July 15, 2011

Comment on: Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease? Reply

scientific article published on 01 July 2019

Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with rheumatoid arthritis and inadequate response to TNF inhibitors: prospective cohort study

scientific article published in the British Medical Journal

Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy

scientific article published on 24 April 2007

Comparison of modified disease-activity scores with original composite scores for prediction of structural damages in rheumatoid arthritis: Data from the ESPOIR cohort

scientific article published on 22 April 2016

Correction to: Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study

scientific article published on 01 May 2019

Corrigendum to "Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome" [Clin. Immunol. 168 (2016) 25-29].

scientific article published on 28 November 2017

Cost-Effectiveness of TNF-Blocker Injection Spacing for Patients with Established Rheumatoid Arthritis in Remission: An Economic Evaluation from the Spacing of TNF-Blocker Injections in Rheumatoid Arthritis Trial

scientific article published on 10 March 2017

Cost-effectiveness analysis of strategies using new immunological diagnostic tests of latent tuberculosis infection before TNF-blockers therapy

scientific article published on 22 February 2018

Cost-effectiveness of rituximab strategies in rheumatoid arthritis

scientific article published in January 2017

Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

scientific article published on 23 August 2016

Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge

scientific article

Current and potential treatments for primary Sjögren's syndrome

scientific article

Cytomegalovirus Colitis and Hypo-IgG After Rituximab Therapy for Rheumatoid Arthritis ⬇️

scientific article published on May 1, 2011

Cytometry by time-of-flight immunophenotyping identifies a blood Sjögren's signature correlating with disease activity and glandular inflammation

scientific article

Decreased B cell activating factor receptor expression on peripheral lymphocytes associated with increased disease activity in primary Sjögren's syndrome and systemic lupus erythematosus

scientific article published on 21 December 2006

Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force

scientific article published on March 2016

Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI).

scientific article published on 5 December 2014

Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome.

scientific article published on 15 September 2017

Development of the ClinESSDAI: a clinical score without biological domain. A tool for biological studies

scientific article published on 25 January 2016

Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy

scientific article

Diagnostic and prognostic relevance of neuromuscular biopsy in primary Sjögren's syndrome-related neuropathy

scientific article published on 01 December 2007

Differentiation of follicular helper T cells by salivary gland epithelial cells in primary Sjögren's syndrome.

scientific article published on 9 January 2014

Discrepancy of Serological and Molecular Patterns of Circulating Epstein-Barr Virus Reactivation in Primary Sjögren's Syndrome

scientific article published on 29 May 2019

Dissociated responses to newer antimyeloma drugs identify a subset of refractory patients with an extremely poor prognosis ⬇️

scientific article published on September 12, 2012

Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?

scientific article

Doses of rituximab for retreatment in rheumatoid arthritis: influence on maintenance and risk of serious infection

scientific article published on 15 December 2017

Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid

scientific article published on February 2013

Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1

scientific article published on 01 June 2018

EBV-specific T-cell response and immunosuppression by methotrexate and TNFalpha antagonists in patients with chronic inflammatory joint disease

scientific article published on 12 October 2007

ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Soluble immune effector molecules [II]: agents targeting interleukins, immunog

scientific article published on 12 February 2018

EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

scientific article published on 22 February 2011

EULAR Sjogren's syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren's syndrome

scientific article

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide

scientific article

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors

scientific article published on 23 April 2020

EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2

scientific article published on 05 June 2020

EULAR recommendations for the management of Sjögren's syndrome with topical and systemic therapies

scientific article published on 31 October 2019

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update

scientific article

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update ⬇️

scientific article published on 6 March 2017

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update

scientific article published on 22 January 2020

Early diagnosis of primary Sjögren's syndrome: EULAR-SS task force clinical recommendations

scientific article published on 22 December 2015

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial

scientific article published on 20 October 2020

Effect of methotrexate and anti-TNF on Epstein-Barr virus T-cell response and viral load in patients with rheumatoid arthritis or spondylarthropathies

scientific article

Effect of response format for clinical vignettes on reporting quality of physician practice

scientific article

Effect of serum anti-tumour necrosis factor (TNF) drug trough concentrations and antidrug antibodies (ADAb) to further anti-TNF short-term effectiveness after switching in rheumatoid arthritis and axial spondyloarthritis

scientific article published on 08 April 2016

Effect of tumor necrosis factor alpha and infliximab on apoptosis of B lymphocytes infected or not with Epstein-Barr virus

scientific article published on March 2006

Effectiveness and safety of abatacept in elderly patients with rheumatoid arthritis enrolled in the French Society of Rheumatology's ORA registry

scientific article published on 27 January 2016

Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial

scientific article

Effects of tumor necrosis factor antagonist treatment on hepatitis C-related immunological abnormalities.

scientific article published in December 2006

Efficacity of a sequential treatment by anti-CD 20 monoclonal antibody and belimumab in type II cryoglobulinaemia associated with primary Sjögren syndrome refractory to rituximab alone

scientific article published on 12 May 2020

Efficacy and safety of belimumab given for 12 months in primary Sjögren's syndrome: the BELISS open-label phase II study

scientific article published on 4 August 2015

Efficacy and safety of belimumab in primary Sjögren's syndrome: results of the BELISS open-label phase II study

scientific article published on 17 December 2013

Efficacy and safety of rituximab in elderly patients with rheumatoid arthritis enrolled in a French Society of Rheumatology registry

scientific article published on September 2014

Efficacy and safety of rituximab in the treatment of refractory inflammatory myopathies in adults: results from the AIR registry

scientific article published on 22 October 2011

Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren's syndrome

scientific article published on 28 October 2019

Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study

scientific article published on June 2016

Efficacy of Epratuzumab, an Anti-CD22 Monoclonal IgG Antibody, in Systemic Lupus Erythematosus Patients with Associated Sjögren's Syndrome: Post-hoc Analyses from the EMBODY Trials

scientific article published on 30 January 2018

Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry

Efficacy of rituximab in the treatment of pulmonary rheumatoid nodules: findings in 10 patients from the French AutoImmunity and Rituximab/Rheumatoid Arthritis registry (AIR/PR registry)

article

Emerging biological therapies in rheumatoid arthritis

scientific article

Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome

scientific article published on 24 December 2019

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort

scientific article

Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area

scientific article published on 01 March 2014

Erratum to: Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis ⬇️

scientific article published on 23 January 2017

Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis

scientific article published on 10 October 2016

Error in the Abstract in the Article by Maldini et al (Arthritis Care Res [Hoboken], March 2014)

scientific article published on 01 May 2014

Evaluation of low-dose rituximab for the retreatment of patients with active rheumatoid arthritis: a non-inferiority randomised controlled trial

scientific article published on 30 May 2013

Evaluation of serum interleukin-6 level as a surrogate marker of synovial inflammation and as a factor of structural progression in early rheumatoid arthritis: results from a French national multicenter cohort

scientific article published on 01 July 2015

Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)

scientific article published on 16 October 2020

Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial

scientific article published on 27 May 2020

Evaluation of two strategies (initial methotrexate monotherapy vs its combination with adalimumab) in management of early active rheumatoid arthritis: data from the GUEPARD trial

scientific article

Evolution of bone densitometry in patients with myeloma treated with conventional or intensive therapy

scientific article published on 01 November 1995

Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort

scientific article

Experience of intravenous immunoglobulin therapy in neuropathy associated with primary Sjögren's syndrome: A national multicentric retrospective study

Exposition to anti-TNF drugs during pregnancy: outcome of 15 cases and review of the literature

scientific article published on 06 December 2008

Expression of BAFF (BLyS) in T cells infiltrating labial salivary glands from patients with Sjögren's syndrome

scientific article published in April 2004

Failure to confirm coxsackievirus infection in primary Sjögren's syndrome.

scientific article

Features of polymyalgia rheumatica-like syndrome after immune checkpoint inhibitor therapy

scientific article published on 18 March 2020

First-year radiographic progression as a predictor of further progression in early arthritis: results of a large national French cohort

scientific article

Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: data from the ESPOIR cohort

scientific article

Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications

scientific article published on 20 July 2018

Functional study of TNF-α promoter polymorphisms: literature review and meta-analysis

scientific article published on June 2011

Genetic contribution of DKK-1 polymorphisms to RA structural severity and DKK-1 level of expression

scientific article published on 24 March 2015

Genetics of rheumatoid arthritis contributes to biology and drug discovery

scientific article

Genome-wide association analysis of anti-TNF drug response in patients with rheumatoid arthritis

scientific article

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

scientific article

Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren's syndrome

scientific article published on 24 October 2013

Germline variation of TNFAIP3 in primary Sjögren's syndrome-associated lymphoma

scientific article published on 2 September 2015

Granulocyte colony-stimulating factor therapy resulting in a flare of systemic lupus erythematosus: comment on the article by Yang and Hamilton

scientific article published in 2001

Guidelines for treatment of primary Sjögren's syndrome: a first useful stone but still much to do.

scientific article published on October 2017

Hepatitis C virus, arthritides, and arthromyalgia

scientific article published in August 2003

High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe

scientific article published on 7 November 2005

How does BAFF activate B cells in patients with autoimmune diseases? ⬇️

scientific article published on February 24, 2012

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project)

scientific article published on 01 May 2018

Hydroxychloroquine levels in patients with systemic lupus erythematosus: whole blood is preferable but serum levels also detect non-adherence

scientific article published on 25 September 2020

Hydroxychloroquine treatment downregulates systemic interferon activation in primary Sjögren's syndrome in the JOQUER randomized trial

scientific article published on 01 January 2020

Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons

scientific article

Idiopathic interstitial lung disease with anti-SSA antibody ⬇️

scientific article published on 08 October 2011

IgA nephropathy associated with ankylosing spondylitis is not controlled by infliximab therapy

scientific article published on 25 June 2009

IgG4-related disease associated with renal microaneurysms and polycythaemia.

scientific article published on 13 October 2015

Imaging for the diagnosis and follow-up of ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion

scientific article published on 30 May 2007

Immune-related adverse events of checkpoint inhibitors

scientific article published on 07 May 2020

Immunization to rituximab is more frequent in systemic autoimmune diseases than in rheumatoid arthritis: ofatumumab as alternative therapy

scientific article published on 09 October 2019

Immunogenicity of tocilizumab in patients with rheumatoid arthritis

scientific article published on 28 June 2016

Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA).

scientific article

Impact of anti-TNF therapy on NK cells function and on immunosurveillance against B-cell lymphomas

scientific article published on 14 February 2017

Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry

scientific article published in November 2017

Improvement in patient-reported outcomes after rituximab in rheumatoid arthritis patients: An open-label assessment of 175 patients

scientific article published on 7 July 2015

Improving accuracy of self-reported diagnoses of rheumatoid arthritis in the French prospective E3N-EPIC cohort: a validation study

scientific article published on 16 December 2019

In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response

scientific article

Incidence and risk factors for adalimumab and infliximab anti-drug antibodies in rheumatoid arthritis: A European retrospective multicohort analysis

scientific article published on 12 October 2018

Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study

scientific article

Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR Cohort

scientific article

Increase of B cell-activating factor of the TNF family (BAFF) after rituximab treatment: insights into a new regulating system of BAFF production

scientific article

Increased Dickkopf-1 in Recent-onset Rheumatoid Arthritis is a New Biomarker of Structural Severity. Data from the ESPOIR Cohort

scientific article

Increased levels of circulating microparticles in primary Sjögren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity

scientific article published on 15 October 2009

Induction of B Cell-Activating Factor by Viral Infection Is a General Phenomenon, but the Types of Viruses and Mechanisms Depend on Cell Type ⬇️

scientific article published on November 3, 2010

Inefficacy of infliximab in primary Sjögren's syndrome: results of the randomized, controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS).

scientific article published on April 2004

Infectious complications of rheumatoid arthritis and psoriatic arthritis during targeted and biological therapies: a viewpoint in 2020

scientific article published on 22 September 2020

Influence of gender on response to rituximab in patients with rheumatoid arthritis: results from the Autoimmunity and Rituximab registry

scientific article published on 11 May 2014

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium

scientific article

Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

scientific article published on January 2006

Integration of sequence data from a Consanguineous family with genetic data from an outbred population identifies PLB1 as a candidate rheumatoid arthritis risk gene

scientific article

Interaction between B-cell activation factor and methotrexate impacts immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis

article

Interleukin 6 receptor inhibition in primary Sjögren syndrome: a multicentre double-blind randomised placebo-controlled trial

scientific article published on 18 November 2020

Interleukin-7/Interferon axis drives T-cell and salivary gland epithelial cell interactions in Sjögren's syndrome

scientific article published on 15 October 2020

International and multidisciplinary expert recommendations for the use of biologics in systemic lupus erythematosus

scientific article

Intravenous Immunoglobulin as an Immunomodulating Agent in Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A French Nationwide Study of Ninety-Two Patients

scientific article published on 01 March 2016

Iron Supplementation-Induced Phosphaturic Osteomalacia: FGF23 is the Culprit

scientific article published on 27 December 2017

Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?

scientific article published on 01 July 2019

Is miR200b-5p a new predictor of lymphoma or associated with lymphocytes infiltrate within salivary glands?

scientific article published on 20 July 2018

Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients

scientific article published on 01 August 2019

JAK inhibitors alter NK cell functions and may impair immunosurveillance against lymphomagenesis

scientific article published on 29 October 2019

Klinefelter's syndrome (47,XXY) is in excess among men with Sjögren's syndrome

scientific article published on 21 April 2016

L'observatoire RATIO : le registre français des infections opportunistes, infections bactériennes graves et lymphomes survenant chez des patients traités ou ayant été traités par anti-TNFα

La cohorte Espoir: un suivi de dix ans des arthrites débutantes en France. Méthodologie et caractéristiques initiales des 813 patients inclus

article

Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study

scientific article

Large granular lymphocyte expansions in primary Sjögren's syndrome: characteristics and outcomes

scientific article published on 17 October 2019

Late-onset neutropenia following rituximab results from a hematopoietic lineage competition due to an excessive BAFF-induced B-cell recovery

scientific article published in February 2007

Link between traditional cardiovascular risk factors and inflammation in patients with early arthritis: Results from a French Multicenter Cohort

article

Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials.

scientific article published on 31 May 2019

Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials.

scientific article

Long-term safety of tofacitinib up to 9.5 years: a comprehensive integrated analysis of the rheumatoid arthritis clinical development programme

scientific article published on 01 October 2020

Low Percentage of Signal Regulatory Protein α/β Memory B Cells in Blood Predicts Development of Anti-drug Antibodies (ADA) in Adalimumab-Treated Rheumatoid Arthritis Patients

scholarly article by Laura Magill et al published 2018 in Frontiers in Immunology

Low back pain in rural Tibet

scientific article published in May 2003

Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren's syndrome: results of the BELISS study

scientific article

Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program

scientific article published on 21 September 2017

Lymphoma, rheumatoid arthritis, and TNFalpha antagonists

scientific article published on 15 April 2010

Lymphomas complicating primary Sjögren's syndrome: from autoimmunity to lymphoma

scientific article published on 05 March 2019

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France

scientific article published in June 2002

Machine learning predicts response to TNF inhibitors in rheumatoid arthritis: results on the ESPOIR and ABIRISK cohorts

scientific article published in 2022

Maintenance of infliximab treatment in ankylosing spondylitis: Results of a one-year randomized controlled trial comparing systematic versus on-demand treatment

scholarly article by Maxime Breban et al published 2007 in Arthritis and Rheumatism

Malignancies associated with tumour necrosis factor inhibitors in registries and prospective observational studies: a systematic review and meta-analysis

scientific article published on September 2011

Malignancy and the Risks of Biologic Therapies: Current Status

scientific article published on 22 October 2016

Management of noninfectious mixed cryoglobulinemia vasculitis: data from 242 cases included in the CryoVas survey

scientific article

Management of rheumatic complications of ICI therapy: a rheumatology viewpoint

scientific article published on 01 December 2019

Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort

scientific article published on 23 July 2009

Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a study

scientific article published on 23 June 2009

Mediterranean diet and risk of rheumatoid arthritis: findings from the French E3N-EPIC cohort study

scientific article published on 09 September 2020

Methotrexate and BAFF interaction prevents immunization against TNF inhibitors

scientific article published on 23 June 2018

Methotrexate therapy for rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

scientific article published on 23 March 2006

Methotrexate treatment and mortality in rheumatoid arthritis

scientific article

Methylation profile of the promoter region of IRF5 in primary Sjögren's syndrome

scientific article published on 01 October 2012

Monoclonal gammopathy of clinical significance: In vivo demonstration of the anti-thrombotic effect of an acquired Anti-Thrombin Antibody

scientific article published on 13 August 2020

Monocyte/Macrophage Abnormalities Specific to Rheumatoid Arthritis Are Linked to miR-155 and Are Differentially Modulated by Different TNF Inhibitors

scientific article published on 04 September 2019

Mucosa-associated lymphoid tissue lymphoma of the thymus: a case report with no evidence of MALT1 rearrangement.

scientific article published on 14 January 2005

Myositis as a manifestation of SARS-CoV-2

scientific article published on 23 April 2020

NCR3/NKp30 contributes to pathogenesis in primary Sjogren's syndrome

scientific article

New 2019 SLE EULAR/ACR classification criteria are valuable for distinguishing patients with SLE from patients with pSS

scientific article published on 09 September 2019

New biological therapies in Sjögren's syndrome

scientific article published on December 2015

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis

scientific article

No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome

scientific article

Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature

scientific article published on 27 August 2015

Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial

scientific article published on September 2016

Nonpharmacological treatments in early rheumatoid arthritis: clinical practice guidelines based on published evidence and expert opinion

scientific article

Off-label use of rituximab for systemic lupus erythematosus in Europe

scientific article

Onset of connective tissue disease following anti-PD1/PD-L1 cancer immunotherapy

scientific article published on 27 February 2017

Orbital Myositis and Primary Sjögren Syndrome.

scientific article published in August 2015

Outcome measures for primary Sjögren's syndrome

scientific article published on 24 February 2012

Outcome measures for primary Sjögren's syndrome: a comprehensive review

scientific article published on 08 January 2014

Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome

scientific article published on 16 July 2015

Paradoxical anti-TNF-associated TB worsening: Frequency and factors associated with IRIS.

scientific article published on 8 December 2015

Passive smoking in childhood increases the risk of developing rheumatoid arthritis

scientific article published on 01 July 2019

Pathogenesis of Sjögren's syndrome and therapeutic consequences ⬇️

scientific article published on September 1, 2010

Patient-perceived flares in rheumatoid arthritis: A sub-analysis of the STRASS treatment tapering strategy trial

scientific article published on 5 December 2016

Pattern of demyelination occurring during anti-TNF-α therapy: a French national survey

article

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

scientific article published on 14 August 2020

Perioperative management of patients with rheumatoid arthritis treated with TNF-alpha blocking agents

scientific article published on 14 June 2007

Pharmacotherapy (excluding biotherapies) for ankylosing spondylitis: development of recommendations for clinical practice based on published evidence and expert opinion

scientific article published on 30 May 2007

Physical examination and laboratory tests in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion

scientific article

Pitfalls for detecting interleukin-33 by ELISA in the serum of patients with primary Sjögren syndrome: comparison of different kits

scientific article published on 9 December 2015

Potential classification criteria for rheumatoid arthritis after two years: results from a French multicenter cohort

scientific article

Potentialisation de la fluindione et de la warfarine par la dexaméthasone dans le myélome multiple et l'amylose AL

scientific article published in October 2007

Potentiation of fluindione or warfarin by dexamethasone in multiple myeloma and AL amyloidosis.

scientific article published on 6 July 2007

Predictive value of tender joints compared to synovitis for structural damage in rheumatoid arthritis

scientific article published on 17 March 2016

Predictors of abatacept retention over 2 years in patients with rheumatoid arthritis: results from the real-world ACTION study

scientific article published on 21 February 2019

Predictors of early relapse in patients with non-infectious mixed cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey.

scientific article published on 10 January 2014

Presence of microchimerism in labial salivary glands in systemic sclerosis but not in Sjögren's syndrome

scholarly article by Selim Aractingi et al published April 2002 in Arthritis and Rheumatism

Prevalence of immune-related systemic adverse events in patients treated with anti-Programmed cell Death 1/anti-Programmed cell Death-Ligand 1 agents: A single-centre pharmacovigilance database analysis

scientific article

Prevalence of primary Sjögren Syndrome: What if Sjögren was right after all?

scientific article published on 19 February 2017

Primary Sjogren’s Syndrome: Time for Prospective Cohorts ⬇️

scientific article published on August 1, 2012

Primary Sjögren's Syndrome

scientific article published on 01 July 2018

Primary Sjögren's Syndrome.

scientific article

Prognostic factors of survival in patients with non-infectious mixed cryoglobulinaemia vasculitis: data from 242 cases included in the CryoVas survey.

scientific article

Quality of life and psychological status in patients with primary Sjögren's syndrome and sicca symptoms without autoimmune features

scientific article published on 01 June 2006

RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone

scientific article published on 01 February 2002

RANK (receptor activator of nuclear factor-kappaB) and RANKL expression in multiple myeloma

scientific article published on 01 April 2002

RANK and RANKL expression in giant-cell tumour of bone

scientific article published on 01 June 2010

Randomized phase II trial of denosumab in patients with bone metastases from prostate cancer, breast cancer, or other neoplasms after intravenous bisphosphonates

scientific article published on 23 February 2009

Rare X chromosome abnormalities in systemic lupus erythematosus and Sjögren's syndrome

scientific article published on 10 July 2017

Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study

scientific article published on 29 December 2017

Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNF dans la spondylarthrite ankylosante et le rhumatisme psoriasique: mise à jour 2007

Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde

Recommandations de la Société française de rhumatologie pour l'utilisation des agents anti-TNFα chez les personnes souffrant de polyarthrite rhumatoïde

Recommendations of the French Society for Rheumatology for managing rheumatoid arthritis

scientific article published on 27 June 2014

Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with ankylosing spondylitis or psoriatic arthritis: 2007 update

scientific article published on 8 November 2007

Recommendations of the French Society for Rheumatology regarding TNFalpha antagonist therapy in patients with rheumatoid arthritis

scientific article published on 29 October 2007

Recommendations of the French Society for Rheumatology. TNFα antagonist therapy in rheumatoid arthritis

article

Refining myositis associated with primary Sjögren's syndrome: data from the prospective cohort ASSESS

scientific article published on 11 August 2020

Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries

scientific article

Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection

scientific article published in July 2002

Renal involvement in primary Sjögren syndrome

scientific article

Reply

Reply

scientific article published in May 2016

Reply: To PMID 25779552

scientific article published on 01 December 2015

Response to: 'Role of interaction between B cells and epithelial cells in pSS' by Pringle et al

scientific article published on 15 October 2020

Retention rates of adalimumab, etanercept and infliximab as first and second-line biotherapy in patients with rheumatoid arthritis in daily practice

scientific article published on 08 April 2014

Retroperitoneal fibrosis secondary to spondylodiscitis after infection with Prevotella

scientific article published on 01 May 2005

Rheumatoid Arthritis of the Hand: Monitoring with a Simplified MR Imaging Scoring Method—Preliminary Assessment ⬇️

scientific article published on July 27, 2010

Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment

scientific article published on 9 June 2017

Risedronate-induced rhabdomyolysis in a patient with inflammatory myopathy

scientific article published on 01 November 2020

Risk factors for total joint arthroplasty infection in patients receiving tumor necrosis factor α-blockers: a case-control study

scientific article

Risk factors of serious infections in patients with rheumatoid arthritis treated with tocilizumab in the French Registry REGATE.

scientific article published on October 2017

Risk of Herpes Zoster in Patients Receiving Anti-TNF-α in the Prospective French RATIO Registry

article

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

scientific article published on 15 June 2016

Rituximab (MabThera) therapy and safety management. Clinical tool guide

scientific article published on 01 June 2008

Rituximab in central nervous system manifestations of patients with primary Sjögren's syndrome: results from the AIR registry.

scientific article

Rituximab-Bendamustine (R-Benda) in MALT lymphoma complicating primary Sjögren syndrome (pSS).

scientific article published on 9 February 2018

Rituximab: a new therapeutic alternative in rheumatoid arthritis

scientific article published on 20 June 2008

Role and modalities of information and education in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion

scientific article

Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sjögren's syndrome

scientific article published in December 2013

Role of good oral hygiene on clinical evolution of rheumatoid arthritis: a randomized study nested in the ESPOIR cohort

scientific article published on 03 September 2019

Role of the IL-12/IL-35 balance in Sjögren's syndrome

scientific article published on 12 September 2017

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry

scientific article published in 2022

Safety and effectiveness of adalimumab in patients with rheumatoid arthritis over 5 years of therapy in a phase 3b and subsequent postmarketing observational study

scientific article published on 27 January 2014

Safety and efficacy of oral direct inhibitors of thrombin and factor Xa in antiphospholipid syndrome.

scientific article published on 09 April 2015

Safety and efficacy of rituximab in systemic lupus erythematosus: results from 136 patients from the French AutoImmunity and Rituximab registry

scientific article published on August 2010

Safety of infliximab used in combination with leflunomide or azathioprine in daily clinical practice

scientific article published on 01 May 2006

Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry

scientific article

Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation

scientific article published on 25 August 2020

Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients

scientific article published on 14 June 2019

Seasonal effect on fatigue, pain and dryness in primary Sjögren's syndrome

scientific article published on 24 February 2020

Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data

scientific article

Serum IL-33 level is associated with auto-antibodies but not with clinical response to biologic agents in rheumatoid arthritis.

scientific article published on 8 June 2018

Serum IL-33, a new marker predicting response to rituximab in rheumatoid arthritis ⬇️

scientific article published on 13 December 2016

Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: results from the ESPOIR cohort ⬇️

scientific article published on April 24, 2012

Serum levels of beta2-microglobulin and free light chains of immunoglobulins are associated with systemic disease activity in primary Sjögren's syndrome. Data at enrollment in the prospective ASSESS cohort

scientific article

Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial

scientific article

Severe chronic bronchiolitis as the presenting feature of primary Sjögren's syndrome.

scientific article published on 2 November 2010

Severe deafness associated with Crohn's disease and spondylarthropathy: successful treatment with anti-TNF.

scientific article published on 7 December 2012

Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR)

scientific article published on 01 May 2019

Sjogren's syndrome is associated with and not secondary to systemic sclerosis

scientific article published on 28 July 2006

Sjögren Syndrome-associated lymphomas: an update on pathogenesis and management

scientific article

Sjögren syndrome

Sjögren's syndrome: state of the art on clinical practice guidelines

Small fiber neuropathy in Sjögren syndrome: Comparison with other small fiber neuropathies

scientific article published on 15 February 2020

Small hepatic vein involvement in IgG multiple myeloma: a very unusual pattern of liver infiltration.

scientific article

Specific cardiomyopathy in lupus patients: report of three cases

scientific article published in January 2004

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

scientific article published on 10 August 2015

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

scientific article

Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity?

scientific article published on 7 September 2004

Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome

scientific article published on 13 December 2016

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid Arthri

scientific article published on 23 June 2015

Structural evaluation in the management of patients with rheumatoid arthritis: development of recommendations for clinical practice based on published evidence and expert opinion

scientific article published in May 2005

Sustainability of TNF-blocker tapering in rheumatoid arthritis over 3 years: long-term follow-up of the STRASS (Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study) randomised controlled trial

scientific article published on 12 September 2017

Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey

scientific article

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients

scientific article published on 01 May 2019

TNF alpha antagonist therapy and safety monitoring

scientific article published on May 2011

TNFR2/BIRC3-TRAF1 signaling pathway as a novel NK cell immune checkpoint in cancer

scientific article published on 11 October 2017

TNFalpha antagonist therapy in ankylosing spondylitis and psoriatic arthritis: recommendations of the French Society for Rheumatology

scientific article published on 30 June 2006

TYK2 protein-coding variants protect against rheumatoid arthritis and autoimmunity, with no evidence of major pleiotropic effects on non-autoimmune complex traits

scientific article

Takayasu Arteritis and Spondyloarthritis: Coincidence or Association? A Study of 14 Cases

scientific article published on 15 April 2017

The 2016-2019 ImmunoTOX assessment board report of collaborative management of immune-related adverse events, an observational clinical study

scientific article published on 12 March 2020

The B cell: a new therapeutic target in rheumatoid arthritis and other autoimmune diseases

scientific article published on 01 September 2004

The CGGGG insertion/deletion polymorphism of theIRF5promoter is a strong risk factor for primary Sjögren's syndrome

scientific article published on 01 July 2009

The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients

scientific article published on 26 July 2007

The IRF5-TNPO3 association with systemic lupus erythematosus has two components that other autoimmune disorders variably share

scientific article

The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnFalpha therapy

scientific article

The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound ⬇️

scientific article published on 7 June 2012

The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study

scientific article published on 30 December 2016

The evolving role of the rheumatologist in the management of immune-related adverse events (irAEs) caused by cancer immunotherapy

scientific article published on 19 September 2017

The high rate of bone resorption in multiple myeloma is due to RANK (receptor activator of nuclear factor-kappaB) and RANK Ligand expression

scientific article published in June 2004

The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries

scientific article published on 18 August 2020

The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases.

scientific article

The unmet need in rheumatology: Reports from the targeted therapies meeting 2017.

scientific article

The unmet need in rheumatology: reports from the Targeted Therapies meeting 2016

scientific article (publication date: 2016)

Therapeutic potential for B-cell modulation in Sjögren's syndrome

scientific article

Therapeutic vaccination with TNF-Kinoid in TNF antagonist-resistant rheumatoid arthritis: a phase II randomized, controlled clinical trial

scientific article

To immunosuppress: whom, when and how? That is the question with COVID-19

scientific article published on 04 August 2020

Tocilizumab as an add-on therapy to glucocorticoids during the first 3 months of treatment of Giant cell arteritis: A prospective study

scientific article published on 24 July 2018

Tocilizumab: therapy and safety management

scientific article published on 17 June 2010

Tolerance and efficacy of rituximab and changes in serum B cell biomarkers in patients with systemic complications of primary Sjögren's syndrome

scientific article

Treat-to-target in systemic lupus erythematosus: recommendations from an international task force.

scientific article published on 16 April 2014

Treatment of multiple myeloma

scientific article published on 01 June 2003

Treatment of primary Sjögren syndrome with rituximab: a randomized trial

scientific article published in February 2014

Tumour necrosis factor alpha -308G->A polymorphism is not associated with response to TNFalpha blockers in Caucasian patients with rheumatoid arthritis: systematic review and meta-analysis

scientific article published on 04 December 2009

Tumour necrosis factor receptor 2 (TNFRSF1B) association study in Sjögren's syndrome

scientific article published on December 2007

Two-year abatacept retention rate in clinical practice in the French ACTION cohort

scientific article published on 25 July 2019

Unending story of the indirect immunofluorescence assay on HEp-2 cells: old problems and new solutions?

scientific article published on 17 April 2018

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018

scientific article published on 02 February 2019

Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019

scientific article published on 29 October 2019

Update of French Society for Rheumatology Recommendations for Managing Rheumatoid Arthritis

article

Updated meta-analysis of non-melanoma skin cancer rates reported from prospective observational studies in patients treated with tumour necrosis factor inhibitors

scientific article

Use of Biologics in Sjögren's Syndrome

scientific article

Use of whole-blood transcriptomic profiling to highlight several pathophysiologic pathways associated with response to rituximab in patients with rheumatoid arthritis: data from a randomized, controlled, open-label trial

scientific article

Usefulness of 18 F-Labeled Fluorodeoxyglucose-Positron Emission Tomography for the Diagnosis of Lymphoma in Primary Sjögren's Syndrome

scientific article published on 14 May 2019

Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study

scientific article published in January 2014

Vaccination recommendations for the adult immunosuppressed patient: A systematic review and comprehensive field synopsis

scientific article published on 2 April 2017

Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI).

scientific article published on 17 January 2014

Valine 11 and phenylalanine 13 have a greater impact on the T-cell response to citrullinated peptides than the 70-74 shared epitope of the DRB1 molecule in macaques

scientific article published on 25 April 2019

Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjögren's syndrome

scientific article published on 6 October 2013

Variants of genes implicated in type 1 interferon pathway and B-cell activation modulate the EULAR response to rituximab at 24 weeks in rheumatoid arthritis

scientific article published on 28 September 2017

Viruses induce high expression of BAFF by salivary gland epithelial cells through TLR- and type-I IFN-dependent and -independent pathways

scientific article published on April 2008

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

scientific article published on 14 September 2015

X Chromosome Dose and Sex Bias in Autoimmune Diseases: Increased Prevalence of 47,XXX in Systemic Lupus Erythematosus and Sjögren's Syndrome

scientific article published on 29 December 2015

[Bone and joints in inflammatory bowel disease]

scientific article published on 01 May 2004

[How to differentiate between useful and useless drugs?]

scientific article published on 01 November 2012

[Pathophysiological advances underlying the biotherapeutic revolution in inflammatory rheumatism]

scientific article published in October 2012

[Pathophysiology of Sjögren's syndrome]

scientific article published on 01 May 2003

[Renal involvement in Sjögren's syndrome]

scientific article published on 15 November 2020

Paulina is supported by:

About Paulina

Help